Effects of Magnesium on Individuals Undergoing Coronary Artery Bypass Graft Surgery

NCT00041392 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

389

Enrollment

OTHER

Sponsor class

Conditions

Coronary Disease
Heart Diseases
Cardiovascular Diseases
Neurologic Manifestations

Interventions

DRUG: Magnesium
DRUG: 0.9% saline

Sponsor

Duke University

Collaborators

[object Object]